CTOs on the Move


 
Create the most delightful experiences for our guests. We believe we can positively change the way people think about alternative lodging. The process begins by seeking out high-quality homes with modern spaces and prime locations, to ensure our designers can bring out the natural beauty of each property and to give you an authentic travel experience. We deck out each Domio with curated furniture, accessories and artwork to create a distinguished level of style and comfort, and provide round-the-clock concierge services for your convenience. With Domio, feel at home anywhere in the world.
  • Number of Employees: 100-250
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Domio raised $50M on 09/24/2018
Domio raised $12M on 10/19/2018
Domio raised $50M on 12/18/2019

Similar Companies

Warhaftig Associates

Warhaftig Associates is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Albion Laboratories

Albion Laboratories is a Clearfield, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MedClean Technologies

MedClean Technologies is a Bethel, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Advocare Group

Advocare Group is a Cleveland, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PharmaBlock Sciences

PharmaBlock Sciences (Nanjing), Inc. is a leading innovative chemistry products and services provider throughout the pharmaceutical R&D process. Its core businesses include: a catalog of specially designed scaffolds and building blocks; custom synthesis; process development; manufacturing of key intermediates and RSMs; and FTE services. The company was listed on Shenzhen Exchange Stock in China on November 10, 2017. PharmaBlock has rapidly gained recognition for its outstanding capability in the design, synthesis, and supply of lab scale building blocks. Building on that success, the company acquired Shandong Diai Biotechnology Co., Ltd. as its pilot plant and manufacturing site in 2016, and is providing scale-up synthesis and manufacturing of key intermediates/RSMs. PharmaBlock is now committed to a more comprehensive and long-term service to valued customers.